Marco Gerlinger (@MarcoGerlinger) header
Marco Gerlinger (@MarcoGerlinger) profile picture

Medical Oncologist and Clinician Scientist working on GI Cancer Genomics/Cancer Evolution, Immunotherapies and Biomarkers

London, England
Joined November 2014
Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)Photo by Marco Gerlinger (@MarcoGerlinger)
We have a Clinical Research Fellow position open at St Barts & Barts Cancer Institute. Ideal for clinicians with an interest to train in oncology and clinical research. qmul-jobs.tal.net/vx/mobile-…
95
We usually spend our days treating GI cancer patients, but we couldn't ignore this incredible piece of evidence from Whipps Cross Hospital, our partner hospital at @NHSBartsHealth. Exceptional delivery room performance! 🏥⚽
2
2
139
Marco Gerlinger retweeted
Delighted to present two pieces of our research at #ESMOGI: 1. TNT with long-course CRT + 3 mo CAPOX in high-risk rectal cancer: efficacy and organ preservation at the Barts Cancer Centre 2. CLDN expression in serial samples from GOA during peri-op FLOT + PDL1 ICI
3
5
15
1,794
Delighted to host our collaborators @DrHongchengZhu and Dr Xia from Fudan University Hospital at @BartsGI_Cancer this week. Working with Prof @MarcoGerlinger, and Drs @LucyKFlanders, Lerner & Nenclares to improved organ preservation strategies in rectal cancer: 40-50% is in reach
2
1
5
448
🔥Just opened: 4 year CLINICAL LECTURERSHIP position in HISTOPATHOLOGY @NHSBartsHealth and my lab @QMBCI in London: for ST3/4 registrars who already hold a PhD/MD. Great opportunity for a deep dive into the immunobiology of MMRd cancer. Deadline 11/04 10am oriel.nhs.uk/Web/Vacancy/Vac…
1
2
548
Still time to register for our free @AACR IO webinar today: “Tumour Mutation Burden, Heterogeneity and Immunotherapy Efficacy”with Profs Jaffe, Quezada and Wargo aacr.org/meeting/aacr-io-dis…
4
5
800
Join the discussion: Pervasive Cellular Plasticity intertwined with Darwinian Evolution in Cancer - does this need a new Evolutionary Theory? See our review just out in @trendscancer sciencedirect.com/science/ar…
2
16
1
40
6,258
Touched down in Miami for the 2024 @CCAlliance #CureCRC Summit - very exciting to be here again to help make this cancer history. Well prepared after lovely Christmas dinner and afternoon tea (‼️‼️) on board of the A380 💪💪💪
2
3
436
Starting from International Exchange Award between UK and China supported by @royalsociety, more exciting opportunities have been discussed for collaboration in clinical and translational research between the two premier centers in London and Shanghai 🇬🇧🇨🇳
1
1
1
14
1,354
Kickoff meeting of our new St Barts Hospital - Fudan University Cancer Centre Oesophageal Cancer Research Collaboration in Shanghai today and yesterday. Very grateful to @RoyalSociary for funding this project which is led by Prof @MarcoGerlinger and Prof Zhen Zhang
1
1
1
6
1,010
Outstanding session with @elena_elez and @BenjcRousseau on immunotherapy biomarkers at @ASCO #ASCO24 this morning. Key messages: Exciting and powerful new IO biomarkers on the horizon. We now need to apply them to large clinical trials including those from industry.
1
12
1,459
Great talk on chromosomal instability by my @QMBCI colleague Dr McClelland @McclellandLab at #AACR24 @AACR in RM29 ongoing
1
4
25
2,401
Marco Gerlinger retweeted
.@politikaterina will be presenting during the Lineage Plasticity in Tumor Evolution and Acquired Resistance educational session at #AACR24, this morning at 8am PST/11am EST. abstractsonline.com/pp8/#!/2… @SmilowCancer @YaleMed @YNHH @yalepathology @YaleThoracic
6
1
25
5,592
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in @CD_AACR today rb.gy/q484j9 Tweetorial👇
6
158
24
498
120,268
Marco Gerlinger retweeted
.@JeffTownsend discussed how the evolution of #cancer is rarely linear, but a branching model that influences progression #AACR24 “Every one of our bodies has a tree of history underlying every cell in our body.” #phylogenetics @AACR @SmilowCancer @YaleMed @YaleSPH
2
12
1,241
Looking forward to meet for a drink (and science discussion of course…)
This Post is from an account that no longer exists. Learn more
403
Important POSTER SESSIONS For those of you at #AACR24: 👉🏻Tumor Evolution in Space and Time is on Monday 9am-12:30 (section 12) 👉🏻Tumor Evolution Models and Technologies on Tuesday 9am-12:30 (section 13) We received 🏅outstanding 🥇 abstracts this year. Don‘t miss out!!
1
6
543
Marco Gerlinger retweeted
What a great start of 2024! Excited, happy and proud to share our latest work published today #openaccess @NatureMedicine on the PANDA trial: neoadjuvant atezo+chemo in pts with gastric/GEJ cancers followed by surgery. Some of the key findings below. 1/10 nature.com/articles/s41591-0…
11
63
13
206
46,588
We're delighted that Prof Tom Powles (@tompowles1) has been selected as one of @Nature's 10 people who shaped science for his transformative clinical work delivering a life-extending treatment for severe bladder cancer. A huge honour – congratulations to Tom and his team 👏👏👏
Nature's 10 | The people who helped shape science in 2023 An AI pioneer, an architect of India’s Moon mission and the world’s first global heat officer are some of the people behind this year’s big stories. Check out the full list: nature.com/immersive/d41586-… #Natures10
1
4
17
3,003
It’s a great honour to be part of the @CCAlliance inaugural #CureCRCsummit this week. Brainstorming strategies to cure #colorectal cancer with giants in the field Drs @skopetz, Batlle, Venook, Lenz, @MyriamChalabi, @AndreaCercek + many others
3
9
1,196